WuXi Biologics is the manufacturing partner of InflaRx for Gohibic (vilobelimab), a first-in-class monoclonal anti-C5a antibody. InflaRx received emerge...
The collaboration agreement combines Angelini Pharma’s expertise in neurological diseases with JCR Pharmaceuticals’ scientific and technologi...
Under the terms of the agreement, Acorda will receive an up-front payment of $2.5 million, a near term milestone payment of up to $6 million, $3 million up...
“We are thrilled to have established a partnership with Dr. Reddy’s while toripalimab’s global commercial network has been steadily expan...
OnKai, a US-based technology company, combines public healthcare and medical innovation experience with complex process digitalization, design thinking, an...
MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem Proposed bioprocessing facility to be based in Daejeon City...
Curasight to develop its proprietary uTRACE® PET imaging technology to obtain regulatory approval in EU and USA, with Curium responsible for man...
PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce the establishment of a 50:50 joint venture, "Cortexa", with Austr...
Merck, a leading science and technology company, held its 28th Annual General Meeting virtually today. All of the resolutions on the agenda were approved, ...
The transaction provides Abbott with a complementary solution for treating vascular disease. CSI's leading atherectomy system prepares vessels for angiopla...
Adcentrx Therapeutics ("Adcentrx"), a biotechnology company dedicated to revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other li...
Furthermore, the Company received notice from the Gardiner Sponsor that the Gardiner Sponsor intends to deposit funds into the trust account under the Trus...
One of the three arbitrators dissented. Genmab has the right to seek review of the award, which it must do within a limited period of time. Genmab is curre...
Aptitude Medical Systems (Aptitude™) announced today that it has received an award up to $53.7 million from Biomedical Advanced Research and Developm...
© 2024 Biopharma Boardroom. All Rights Reserved.
